UCB calls upon UK government for greater incentives for industry partnering

Belgian drugmaker UCB (Euronext Brussels: UCB) has called for further collaboration in life sciences to enhance drug discovery and help drive economic growth at its networking event at the Royal College of Surgeons for PhD scientists.

The event also featured a talk from MedCity’s chief operating officer, Sarah Haywood, who spoke of the importance of collaboration and the UK’s world-leading reputation in life sciences.

Eliot Forster, executive chair of MedCity, said: “The UK’s reputation as a global center for creative, innovative science is underpinned by the pipeline of talented students coming through our world-leading universities. These are the people who will be tomorrow’s research and industry leaders, whose skills and knowledge will keep this country punching above its weight in the global economy. It’s great to see UCB working with universities to support their development and facilitate networking and collaboration.”